Lilly, Boehringer launch combo diabetes pill; Anti-counterfeiting bill gains steam on phony Avastin news;

@FiercePharma: More OTC drugs? FDA may allow more meds to go non-prescription. Consumer-use studies still required. Story | Follow @FiercePharma

> Eli Lilly ($LLY) and Boehringer Ingelheim launched their new combo drug Jentadueto--which comprises BI's Tradjenta and the commonly used generic metformin--in the U.S. Report

> Amag Pharmaceuticals ($AMAG) said its Feraheme anemia treatment, now targeted at patients with chronic kidney disease, worked as well as standard therapy in patients with cancer, gastrointestinal problems and abnormal uterine bleeding. News

> An anti-counterfeiting bill has gathered fresh steam on news of phony Avastin surfacing in the U.S. supply chain. Item

> Pinpointing the genetic characteristics of cancers is complicated, best done with multiple samples and repeatedly, during treatment, to make sure the correct drugs are used to target tumors, a study found. More

> Almac Pharma Services is moving deeper into the U.S. market with a new, $10 million commercial packaging operation in Audubon, PA. Piece

> FDA released new draft guidance for classifying post-marketing safety issues, designed to help the agency better prioritize its responses. Report

Biotech News

@FierceBiotech: Navy maneuvers to bombard dengue fever in vaccine study. Story | Follow @FierceBiotech

@JohnCFierce: J&J wows analysts with early success of Zytiga Ph3 for prostate cancer. News | Follow @JohnCFierce

@RyanMFierce: Props to Bellicum Pharma, not only for the new $20M B round, but also for the transparent explanation of the deal. Release | Follow @RyanMFierce

> NeurogesX slashes staff, shifts R&D direction after FDA slaps down app. News

> Promedior lands $21.5M D round for fibrosis pipeline. Article

> Bellicum snags $20M for cancer vaccine program. Item

Manufacturing News

> AMRI names quality control director for troubled plant, following lead of J&J, Novartis, others. Item

> Almac builds on U.S. expansion with $10M pharmaceutical packaging plant. Article

CRO News

> Biosimilars growth draws contract labs into the fray. More

> Survey: Look for strong growth in R&D outsourcing, shift to India and China. Report

> Frustrated Pfizer seeks Euro recruitment contractor for 'virtual' trial. Article

> Survey zeroes in on CRO frustrations. Item

Vaccines News

> Is Agenus on GSK's shopping list? More

> Inovio vaccine targets head and neck HPV subtypes. Report

> Gradalis' personalized cancer vaccine has FANGs. Story

> Microneedles trigger better responses to flu vaccine. Article

And Finally... After a crackdown on pill mills, Florida's pain-drug trade has moved to retail pharmacies. Article

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.